Down Syndrome: From Pregnancy through Childhood in Türkiye

dc.contributor.authorGulec, Elif Yilmaz
dc.contributor.authorCetin, Sena
dc.contributor.authorGunes, Mustafa
dc.contributor.authorGezdirici, Alper
dc.date.accessioned2025-11-16T19:34:19Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractIntroduction: Down syndrome is the most common genetic cause of multiple congenital malformations and intellectual disability. The prevalence of the disorder and accompanying malformations, prenatal and postnatal features, and clinical approach to the syndrome vary across different regions worldwide. This study aims to share our clinic's experience with Down syndrome from pregnancy through childhood from a medical geneticist's perspective and to summarize the prenatal and postnatal characteristics of our patients. Methods: A 10-year review of medical records was conducted for patients with Down syndrome who were followed between 2010 and 2021. Patient data including sex, karyotype, follow-up period, age at first and last visit, congenital malformations, organic disorders, prenatal screening data, neonatal history, neuromotor developmental milestones, and growth parameters were evaluated. Results: Overall, 324 children with Down syndrome were evaluated. Overall, 95% (308) had regular trisomy 21. The mean age at admission was 6.09 +/- 1.99 months, and patients were followed for an average of 32.7 +/- 3.97 months. Overall, 51% of neonates and 53.5% overall were hospitalized. While common disorders such as congenital heart defects (57.5%), neonatal hyperbilirubinemia (19.7%), and hypothyroidism (39%) were observed, rare conditions such as polydactyly, Ebstein anomaly, epilepsy, epileptic encephalopathy, nephrolithiasis, and cholelithiasis were also reported. Conclusion: The clinical features of Down syndrome observed in T & uuml;rkiye have been summarized through our cohort. Medical teams need comprehensive knowledge about Down syndrome management. Childhood is recognized as a critical period in Down syndrome care, particularly regarding early diagnosis and treatment of congenital malformations and management of developmental delays.
dc.identifier.doi10.1159/000548225
dc.identifier.issn1661-8769
dc.identifier.issn1661-8777
dc.identifier.urihttps://doi.org/10.1159/000548225
dc.identifier.urihttps://hdl.handle.net/20.500.14730/15312
dc.identifier.wosWOS:001604126000001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofMolecular Syndromology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectDown syndrome
dc.subjectTrisomy 21
dc.subjectPrenatal findings
dc.subjectPostnatal findings
dc.subjectRare features
dc.titleDown Syndrome: From Pregnancy through Childhood in Türkiye
dc.typeArticle

Dosyalar